1. Home
  2. CCC vs AMRX Comparison

CCC vs AMRX Comparison

Compare CCC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCC Intelligent Solutions Holdings Inc.

CCC

CCC Intelligent Solutions Holdings Inc.

N/A

Current Price

$4.78

Market Cap

3.6B

Sector

Technology

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.80

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCC
AMRX
Founded
1980
2002
Country
United States
United States
Employees
2185
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.7B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CCC
AMRX
Price
$4.78
$12.80
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$8.94
$15.60
AVG Volume (30 Days)
9.0M
1.4M
Earning Date
04-30-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.22
Revenue
N/A
N/A
Revenue This Year
$10.22
$4.48
Revenue Next Year
$8.58
$7.13
P/E Ratio
N/A
$57.57
Revenue Growth
N/A
N/A
52 Week Low
$4.68
$7.02
52 Week High
$8.68
$15.42

Technical Indicators

Market Signals
Indicator
CCC
AMRX
Relative Strength Index (RSI) 34.44 49.87
Support Level N/A $12.50
Resistance Level $6.34 $12.85
Average True Range (ATR) 0.29 0.49
MACD -0.06 -0.01
Stochastic Oscillator 15.75 30.56

Price Performance

Historical Comparison
CCC
AMRX

About CCC CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: